BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
4.200
-0.160 (-3.67%)
At close: Jun 27, 2025, 4:00 PM
4.150
-0.050 (-1.19%)
After-hours: Jun 27, 2025, 7:32 PM EDT
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $150.57 million as of June 27, 2025.
Market Cap
150.57M
Enterprise Value
-174.19M
1-Year Change
n/a
Ranking
Category
Stock Price
4.20
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $150.57M, a decrease of -75.52%. That is a compound annual growth rate of -84.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 150.57M | -27.46% |
| Dec 31, 2024 | 207.56M | -66.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |